Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Legless duck walks again with 3D printed prosthetic feet built by middle schoolers

Add as a preferred source on Google

When Philip the duck was rescued in this year’s harsh Wisconsin winter, a terrible case of frostbite had caused him to lose both feet. But thanks to some creative young minds, 3D printing has helped him get back on his feet. A middle school class at a local Wisconsin school put their technology and engineering lessons to good use by 3D printing a pair of duck feet that have Philip up and waddling once again.

Vicki Rabe-Harrison thought that Philip would never walk again when she rescued him this past winter. The duck was clearly handicapped, and Rabe-Harrison thought she might have to put him down to relieve him from his pain. Then she stumbled across the videos Jason Jischke’s South Park Middle School class had posted online, showcasing their MakerBot Replicator Mini in action. When she emailed Jischke as a last resort option to help her help Philip, his entire class stepped up.

Recommended Videos

Jischke and his class full of middle school students immediately set to work 3D printing a pair of custom artificial duck feet. They weren’t sure that Philip would be able to balance wearing them, but their efforts paid off in a perfectly timed surprise. When they informed Rabe-Harrison they had the prosthetics ready, she was just an hour way from putting Philip down.

Since then, Jischke and his students have iterated through more than six different prototypes to get Philip’s prosthetic duck feet just right. The most recent prototype is made with Ninjaflex, and each “webbed” foot is designed to slide onto Philips’ legs to help him walk and waddle naturally. Through trial and error and a lot of waddling practice, Philip is learning to balance again. Hopes are high that in time, Philip will even be able to swim again once he gets used to using his 3D printed feet.

Chloe Olewitz
Former Digital Trends Contributor
Chloe is a writer from New York with a passion for technology, travel, and playing devil's advocate. You can find out more…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more